 
          手机扫码访问本站
 
 
        微信咨询
	
	
	 
						Background:
					 
						This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1;19), with PBX1), childhood leukemia (t(19;19), with TFPT) and acute leukemia (t(12;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Sep 2011]
					 
						Applications:
					 
						IHC
					 
						Name of antibody:
					 
						TCF3(Phospho-Thr355)
					 
						Immunogen:
					 
						Peptide sequence around phosphorylation site of threonine 355 (P-S-T(p)-P-V) derived from Human E2A .
					 
						Full name:
					 
						transcription factor 3
					 
						Synonyms:
					 
						E2A; E47; ITF1; VDIR; TCF-3; bHLHb21
					 
						SwissProt:
					 
						P15923
					 
						IHC positive control:
					 
						Human brain tissue
					 
						IHC Recommend dilution:
					 
						50-100
					
		
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
			
					 
				
					 
			
				 
		
	
					 
				
					 
			
	
	